Hypoxia, HIF1 and glucose metabolism in the solid tumour
The DOI matches its Crossref record; 126 of the 126 references it cites were found in a registry or an index.
Abstract
It has been known for many years that cellular metabolism within the solid tumour is markedly different from that of the corresponding normal tissue. The transcription factor hypoxia-inducible factor 1 (HIF1) has been implicated in regulating many of the genes that are responsible for the metabolic difference. However, it remains unclear how this 'aerobic glycolysis', originally described by Otto Warburg, offers tumour cells a growth advantage. As discussed in this Perspective, new data suggests that this metabolic switch may provide a benefit to the tumour not by increasing glycolysis but by decreasing mitochondrial activity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Activated HIF-1 plays a crucial role in adaptive responses of the tumor cells to changes in oxygen through transcriptional activation of over 100 downstream genes which regulate vital biological processes required for tumor survival and progression.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1 mediates this metabolic conversion through the induction of enzymes involved in the glycolysis pathway and overexpression of glucose transporters (GLUTs) which increase glucose import into tumor cells3.”
From HIF-1α pathway: role, regulation and intervention for cancer therapy (2015) · cites this paper as [3]
In the citing paper
“HIF-1α is activated due to blockade of its degradation pathway mediated by low oxygen levels, thereby increasing the expression of target genes, including those encoding glycolytic enzymes and glucose transporters, and increasing lactate secretion67.”
From Glutamine reliance in cell metabolism (2020) · cites this paper as [67]
Citations
Cites
Free Radicals in the Physiological Control of Cell Function
Dröge, W. (2002) · Physiological Reviews · doi:10.1152/physrev.00018.2001 · Cited by 9,855
Targeting HIF-1 for cancer therapy
Semenza, G. L. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1187 · Cited by 6,717
Jaakkola, P., Mole, D. R., Tian, Y.-M., Wilson, M. I., Gielbert, J., Gaskell, S. J., Kriegsheim, A. V., Hebestreit, H. F., Mukherji, M., Schofield, C. J., et al. (2001) · Science · doi:10.1126/science.1059796 · Cited by 5,535
The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
Maxwell, P. H., Wiesener, M. S., Chang, G.-W., Clifford, S. C., Vaux, E. C., Cockman, M. E., Wykoff, C. C., Pugh, C. W., Maher, E. R., & Ratcliffe, P. J. (1999) · Nature · doi:10.1038/20459 · Cited by 5,180
Why Do Cancers Have High Aerobic Glycolysis?
Gatenby, R. A., & Gillies, R. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1478 · Cited by 4,784
HIFα Targeted for VHL-Mediated Destruction by Proline Hydroxylation: Implications for O 2 Sensing
Ivan, M., Kondo, K., Yang, H., Kim, W., Valiando, J., Ohh, M., Salic, A., Asara, J. M., Lane, W. S., & Kaelin Jr., W. G. (2001) · Science · doi:10.1126/science.1059817 · Cited by 4,735
Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905
On Respiratory Impairment in Cancer Cells
Warburg, O. (1956) · Science · doi:10.1126/science.124.3215.269 · Cited by 3,468
Epstein, A. C. R., Gleadle, J. M., McNeill, L. A., Hewitson, K. S., O'Rourke, J., Mole, D. R., Mukherji, M., Metzen, E., Wilson, M. I., Dhanda, A., et al. (2001) · Cell · doi:10.1016/s0092-8674(01)00507-4 · Cited by 3,333
Tumor Hypoxia: Definitions and Current Clinical, Biologic, and Molecular Aspects
Hockel, M., & Vaupel, P. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.266 · Cited by 2,662 · cited 1×
“Tumour cells respond to these conditions, and adapt their metabolism to adjust the O 2 demand to meet the limited suppl”
Background
Cited by
Items 601–700 of 1,002
Epigallocatechin gallate inhibits human tongue carcinoma cells via HK2-mediated glycolysis
Gao, F., Li, M., Liu, W., ZHOU, Z.-S., Zhang, R., LI, J.-L., & Zhou, K. (2015) · Oncology Reports · doi:10.3892/or.2015.3727 · Cited by 54
Li, X., Yu, X., Dai, D., Song, X., & Xu, W. (2016) · Oncotarget · doi:10.18632/oncotarget.8153 · Cited by 55
Extracellular acidity as favouring factor of tumor progression and metastatic dissemination.
Calorini, L., Peppicelli, S., & Bianchini, F. (2012) · PubMed · Cited by 64
uPA/uPAR system activation drives a glycolytic phenotype in melanoma cells
Laurenzana, A., Chillà, A., Luciani, C., Peppicelli, S., Biagioni, A., Bianchini, F., Tenedini, E., Torre, E., Mocali, A., Calorini, L., et al. (2017) · International Journal of Cancer · doi:10.1002/ijc.30817 · Cited by 53
Huang, C., Li, Y., Li, Z., Xu, Y., Li, N., Ge, Y., Dong, J., Chang, A., Zhao, T., Wang, X., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-3533 · Cited by 61
LKB1 and Tumor Metabolism: The Interplay of Immune and Angiogenic Microenvironment in Lung Cancer
Bonanno, L., Zulato, E., Pavan, A., Attili, I., Pasello, G., Conte, P., & Indraccolo, S. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081874 · Cited by 57
He, G., Pan, X., Liu, X., Zhu, Y., Ma, Y., Du, C., Liu, X., & Mao, C. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c12139 · Cited by 55
Bianchi, C., Bombelli, S., Raimondo, F., Torsello, B., Angeloni, V., Ferrero, S., Stefano, V. D., Chinello, C., Cifola, I., Invernizzi, L., et al. (2010) · American Journal Of Pathology · doi:10.2353/ajpath.2010.090402 · Cited by 54
Zhou, Y., Tong, F., Gu, W., He, S., Yang, X., Li, J., Gao, Y., & Gao, H. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.12.001 · Cited by 52
Li, Y., Liu, Y., Xu, J., Chen, D., Wu, T., & Cao, Y. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.3c03001 · Cited by 54
Mitochondrial Metabolism Inhibitors for Cancer Therapy
Ramsay, E. E., Hogg, P. J., & Dilda, P. J. (2011) · Pharmaceutical Research · doi:10.1007/s11095-011-0584-5 · Cited by 57
Sato, J., Kitagawa, Y., Yamazaki, Y., Hata, H., Okamoto, S., Shiga, T., Shindoh, M., Kuge, Y., & Tamaki, N. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.114355 · Cited by 57
Treps, L., Conradi, L., Harjes, U., & Carmeliet, P. (2016) · Pharmacological Reviews · doi:10.1124/pr.116.012492 · Cited by 57
New options for the anemia of chronic kidney disease
Coyne, D. W., Goldsmith, D. J. A., & Macdougall, I. C. (2017) · Kidney International Supplements · doi:10.1016/j.kisu.2017.09.002 · Cited by 63
Metabolic changes in bladder cancer
Woolbright, B. L., Ayres, M., & Taylor, J. A. (2018) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2018.04.010 · Cited by 58
Expression of MMIF, HIF-1α and VEGF in Serum and Endometrial Tissues of Patients with Endometriosis
Zhang, F., Liu, X., Wang, W., Dong, H., Xia, Y.-F., Ruan, L.-P., & Liu, L. (2018) · Current Medical Science · doi:10.1007/s11596-018-1906-1 · Cited by 54
ERK Regulates HIF1α-Mediated Platinum Resistance by Directly Targeting PHD2 in Ovarian Cancer
Li, Z., Zhou, W., Zhang, Y., Sun, W., Yung, M. M. H., Sun, J., Li, J., Chen, C.-W., Li, Z., Meng, Y., et al. (2019) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-18-4145 · Cited by 48
A positive self-amplified H2O2 and acidity circulation for boosting CDT-PTT-starvation therapy
Rao, Y., Fan, T., Zhou, L., Fang, K., Sun, Y., Hu, X., Wang, A., Li, R., Zhu, Z., Dong, C., et al. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.01.053 · Cited by 51
Li, W., Nichols, K., Nathan, C. O., & Zhao, Y. (2013) · Cancer Biomarkers · doi:10.3233/cbm-130369 · Cited by 54
Locasale, J. W., Cantley, L. C., & Heiden, M. G. V. (2009) · Nature Biotechnology · doi:10.1038/nbt1009-916 · Cited by 54
Sakamoto, T., & Seiki, M. (2017) · Cancer Science · doi:10.1111/cas.13231 · Cited by 55
Synergistic Multimodal Cancer Therapy Using Glucose Oxidase@CuS Nanocomposites
Singh, P., Youden, B., Yang, Y., Chen, Y., Carrier, A. J., Cui, S., Oakes, K. D., Servos, M. R., Jiang, R., & Zhang, X. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c12235 · Cited by 53
el Maaty, M. A. A., Terzic, J., Keime, C., Rovito, D., Lutzing, R., Yanushko, D., Parisotto, M., Grelet, É., Namer, I. J., Lindner, V., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo2295 · Cited by 56
Metabolic Pathways, Enzymes, and Metabolites: Opportunities in Cancer Therapy
Kumar, R., Mishra, A., Gautam, P., Feroz, Z., Vijayaraghavalu, S., Likos, E., Shukla, G. C., & Kumar, M. (2022) · Cancers · doi:10.3390/cancers14215268 · Cited by 55
Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics
Pal, S., Sharma, A. K., Mathew, S. P., & Jaganathan, B. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955476 · Cited by 56
Design and Synthesis of Novel Small-Molecule Inhibitors of the Hypoxia Inducible Factor Pathway
Mooring, S. R., Jin, H., Devi, N. S., Jabbar, A. A., Kaluz, S., Liu, Y., Van Meir, E. G., & Wang, B. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm201018g · Cited by 49
van Osch, F., Voets, A. M., Schouten, L. J., Gottschalk, R. W. H., Simons, C. C. J. M., van Engeland, M., Lentjes, M. H. F. M., van den Brandt, P. A., Smeets, H. J. M., & Weijenberg, M. P. (2015) · Carcinogenesis · doi:10.1093/carcin/bgv151 · Cited by 54
Ubiquitination regulation of aerobic glycolysis in cancer
Xie, Y., Wang, M., Xia, M. H., Guo, Y., Zu, X., & Zhong, J. (2022) · Life Sciences · doi:10.1016/j.lfs.2022.120322 · Cited by 54
Extracellular ATP promotes breast cancer chemoresistance via HIF-1α signaling
Yang, H., Geng, Y., Wang, P., Zhang, H., Fang, W., & Tian, X. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04647-6 · Cited by 57
Hypoxia and Metabolism in Cancer
Bensaad, K., & Harris, A. L. (2013) · Advances in experimental medicine and biology · doi:10.1007/978-1-4614-5915-6_1 · Cited by 53
Valle‐Casuso, J. C., González-Sánchez, A., Medina, J. M., & Tabernero, A. (2012) · PLoS ONE · doi:10.1371/journal.pone.0032448 · Cited by 53
Plecitá‐Hlavatá, L., Ježek, J., & Ježek, P. (2009) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.02.015 · Cited by 55
Sakuma, Y., Matsukuma, S., Nakamura, Y., Yoshihara, M., Koizume, S., Sekiguchi, H., Saito, H., Nakayama, H., Kameda, Y., Yokose, T., et al. (2013) · Laboratory Investigation · doi:10.1038/labinvest.2013.102 · Cited by 49
Overexpression of HIF1α and CAXI predicts poor outcome in early-stage triple negative breast cancer
Jin, M., Lee, H., Park, I. A., Chung, Y. R., Im, S., Lee, K.-H., Moon, H., Han, W., Kim, K., Kim, T., et al. (2016) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-016-1953-6 · Cited by 49
Mitonuclear Interactions Mediate Transcriptional Responses to Hypoxia inDrosophila
Mossman, J. A., Tross, J. G., Jourjine, N. A., Li, N., Wu, Z. J., & Rand, D. M. (2016) · Molecular Biology and Evolution · doi:10.1093/molbev/msw246 · Cited by 62
RER1 enhances carcinogenesis and stemness of pancreatic cancer under hypoxic environment
Chen, S., Zhang, J., Chen, J., Wang, Y., Zhou, S., Huang, L., Bai, Y., Peng, C., Shen, B., Chen, H., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0986-x · Cited by 54
Resistance to anoikis in transcoelomic shedding: the role of glycolytic enzymes
Wilson, R. B., Solaß, W., Archid, R., Weinreich, F., Königsrainer, A., & Reymond, M. A. (2019) · Pleura and Peritoneum · doi:10.1515/pp-2019-0003 · Cited by 52
PRMT3 promotes tumorigenesis by methylating and stabilizing HIF1α in colorectal cancer
Zhang, X., Wang, K., Feng, X., Wang, J., Chu, Y., Jia, C., He, Q., & Chen, C. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04352-w · Cited by 49
Dziurla, R., Gaber, T., Fangradt, M., Hahne, M., Tripmacher, R., Kolar, P., Spies, C. M., Burmester, G. R., & Buttgereit, F. (2010) · Immunology Letters · doi:10.1016/j.imlet.2010.02.008 · Cited by 52
Wang, P., Lan, C., Xiong, S., Zhao, X., Shan, Y., Hu, R., Wan, W., Yu, S., Liao, B., Li, G., et al. (2017) · Oncotarget · doi:10.18632/oncotarget.15888 · Cited by 48
Genetically Encoded ATP Biosensors for Direct Monitoring of Cellular ATP Dynamics
White, D., & Yang, Q. (2022) · Cells · doi:10.3390/cells11121920 · Cited by 50
Hundahl, C. A., Luuk, H., Ilmjärv, S., Falktoft, B., Raida, Z., Vikesaa, J., Friis-Hansen, L. J., & Hay‐Schmidt, A. (2011) · PLoS ONE · doi:10.1371/journal.pone.0028160 · Cited by 51
Scott, A. J., Arcaroli, J. J., Bagby, S. M., Yahn, R., Huber, K. M., Serkova, N. J., Nguyen, A., Kim, J., Thorburn, A., Vogel, J., et al. (2018) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-17-0131 · Cited by 48
Anoikis Resistance as a Further Trait of Acidic-Adapted Melanoma Cells
Peppicelli, S., Ruzzolini, J., Bianchini, F., Andreucci, E., Nediani, C., Laurenzana, A., Margheri, F., Fibbi, G., & Calorini, L. (2019) · Journal of Oncology · doi:10.1155/2019/8340926 · Cited by 49
Cancer Etiology: A Metabolic Disease Originating from Life’s Major Evolutionary Transition?
Poljšak, B., Kovač, V., Dahmane, R. G., Levec, T., & Starc, A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7831952 · Cited by 51
Molecular Mechanism of Autophagy and Its Regulation by Cannabinoids in Cancer
Lee, X. C., Werner, E., & Falasca, M. (2021) · Cancers · doi:10.3390/cancers13061211 · Cited by 50
Glycolysis in tumor microenvironment as a target to improve cancer immunotherapy
Xiao, C., Tian, H., Zheng, Y., Yang, Z., Li, S., Fan, T. T., Xu, J., Bai, G., Liu, J., Deng, Z., et al. (2022) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2022.1013885 · Cited by 58
Bischoff, P. L., Altmeyer, A., & Dumont, F. J. (2009) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543770902824172 · Cited by 52
EBV Infection and Its Regulated Metabolic Reprogramming in Nasopharyngeal Tumorigenesis
Yang, T., You, C., Meng, S., Lai, Z., Ai, W., & Zhang, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935205 · Cited by 50
Chen, Y., Liu, Y., Lee, C., Pham, K., Manoharan, D., Thangudu, S., Su, C., & Yeh, C. (2022) · Advanced Healthcare Materials · doi:10.1002/adhm.202201613 · Cited by 60
Metabolic adaptations of cancer in extreme tumor microenvironments
Nakahara, R., Maeda, K., Aki, S., & Osawa, T. (2023) · Cancer Science · doi:10.1111/cas.15722 · Cited by 49
Liu, F., Zhang, W., You, X., Liu, Y., Li, Y., Wang, Z., Wang, Y., Zhang, X., & Ye, L. (2015) · Oncotarget · doi:10.18632/oncotarget.4508 · Cited by 49
de Gruijl, F. R., Koehl, G. E., Voskamp, P., Strik, A. S., Rebel, H. G., Gaumann, A. K. A., de Fijter, J. W., Tensen, C. P., Bavinck, J. N. B., & Geissler, E. K. (2009) · International Journal of Cancer · doi:10.1002/ijc.25097 · Cited by 47
Metabolic Alterations of Thyroid Cancer as Potential Therapeutic Targets
Ciavardelli, D., Bellomo, M., Consalvo, A., Crescimanno, C., & Vella, V. (2017) · BioMed Research International · doi:10.1155/2017/2545031 · Cited by 48
On-demand quantitative SERS bioassays facilitated by surface-tethered ratiometric probes
Zhang, K., Wang, Y., Wu, M., Liu, Y., Shi, D., & Liu, B. (2018) · Chemical Science · doi:10.1039/c8sc03263g · Cited by 49
Cachexia Anorexia Syndrome and Associated Metabolic Dysfunction in Peritoneal Metastasis
Archid, R., Solaß, W., Tempfer, C., Königsrainer, A., Adolph, M., Reymond, M. A., & Wilson, R. B. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215444 · Cited by 50
The role of mitochondria in the resistance of melanoma to PD-1 inhibitors
Du, F., Yang, L.-H., Liu, J., Wang, J., Fan, L., Duangmano, S., Liu, H., Liu, M., Wang, J., Zhong, X., et al. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-04200-9 · Cited by 54
Blockage of glycolysis by targeting PFKFB3 suppresses the development of infantile hemangioma
Yang, K., Qiu, T., Zhou, J., Gong, X., Zhang, X., Lan, Y., Zhang, Z., & Ji, Y. (2023) · Journal of Translational Medicine · doi:10.1186/s12967-023-03932-y · Cited by 51
Recent advances in the metal/organic hybrid nanomaterials for cancer theranostics
Ye, Z., Bao, Y., Chen, Z., Ye, H., Feng, Z., Li, Y., Zeng, Y., Pan, Z., Ouyang, D., Zhang, K., et al. (2024) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2023.215654 · Cited by 48
Medjkane, S., Perichon, M., Marsolier, J., Dairou, J., & Weitzman, J. B. (2013) · Oncogene · doi:10.1038/onc.2013.134 · Cited by 52
Prognostic significance of hypoxic PET using 18 F-FAZA and 62 Cu-ATSM in non-small-cell lung cancer
Kinoshita, T., Fujii, H., Hayashi, Y., Kamiyama, I., Ohtsuka, T., & Asamura, H. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.11.020 · Cited by 47
Moench, R., Grimmig, T., Kannen, V., Tripathi, S., Faber, M., Moll, E.-M., Chandraker, A. K., Lissner, R., Germer, C., Waaga-Gasser, A. M., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.11899 · Cited by 47
The Interplay between Oncogenic Signaling Networks and Mitochondrial Dynamics
Nagdas, S., & Kashatus, D. F. (2017) · Antioxidants · doi:10.3390/antiox6020033 · Cited by 49
Jiang, Z., Wang, X., Li, J., Yang, H., & Lin, X. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13732 · Cited by 46
He, G., Yang, C., Hang, T., Liu, D., Chen, H., Zhang, A.-H., Lin, D. H., Wu, J., Yang, B., & Xie, X. (2018) · ACS Sensors · doi:10.1021/acssensors.8b00367 · Cited by 48
Li, R., Li, H., Zhu, L., Zhang, X., Liu, D., Li, Q., Ni, B., Hu, L.-P., Zhang, Z., Zhang, Y., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04391-3 · Cited by 53
Yu, H., Yang, W., Huang, J., Miao, X., Wang, B., Ren, X., Gu, Y., Wang, Q., Ding, X., Guo, X., et al. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04394-0 · Cited by 46
Surface functionalized biomimetic bioreactors enable the targeted starvation-chemotherapy to glioma
Ke, R., Zhen, X., Wang, H., Li, L., Wang, H., Wang, S., & Xie, X. (2021) · Journal of Colloid and Interface Science · doi:10.1016/j.jcis.2021.12.009 · Cited by 47
Wang, X., Song, H., Liang, J., Jia, Y., & Zhang, Y. (2022) · Molecular Medicine Reports · doi:10.3892/mmr.2022.12871 · Cited by 47
Cao, K., Zhang, T.-J., Li, Z., Song, M., Li, A., Yan, J., Guo, S., Wang, L.-T., Huang, S.-Q., Li, Z., et al. (2023) · Journal of Pathology · doi:10.1002/path.6052 · Cited by 45
Jang, Y., Han, J., Kim, S., Kim, J., Lee, M. J., Jeong, S., Ryu, M. J., Seo, K.-S., Choi, S., Shong, M., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.5511 · Cited by 45
Haan, C., Walbrecq, G., Kozar, I., Behrmann, I., & Zimmer, A. D. (2016) · Hypoxia · doi:10.2147/hp.s99044 · Cited by 50
Pathophysiological mechanisms of death resistance in colorectal carcinoma
Huang, C., & Yu, L. C. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i41.11777 · Cited by 46
The receptor for advanced glycation end products: A fuel to pancreatic cancer
Shahab, U., Ahmad, M. K., Mahdi, A. A., Waseem, M., Arif, B., Moinuddin, M., & Ahmad, S. (2017) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2017.07.010 · Cited by 47
In Vivo Extracellular pH Mapping of Tumors Using Electron Paramagnetic Resonance
Komarov, D. A., Ichikawa, Y., Yamamoto, K., Stewart, N. J., Matsumoto, S., Yasui, H., Kirilyuk, I. A., Khramtsov, V. V., Inanami, O., & Hirata, H. (2018) · Analytical Chemistry · doi:10.1021/acs.analchem.8b03328 · Cited by 45
Ying, M., Guo, C., & Hu, X. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.007841 · Cited by 48
Characterization of glycolysis-related gene expression in malignant melanoma
Koch, A., Ebert, E. V., Seitz, T., Dietrich, P., Berneburg, M., Bosserhoff, A., & Hellerbrand, C. (2019) · Pathology - Research and Practice · doi:10.1016/j.prp.2019.152752 · Cited by 46
Yang, C., Gao, Y., Fan, Y., Cao, L., Li, J., Ge, Y., Tu, W., Liu, Y., Cao, X., & Shi, X. (2020) · Theranostics · doi:10.7150/thno.54930 · Cited by 45
Wu, C., Hsu, Y.-H., Chen, Y., Yang, L., Tseng, S., Chen, W., Huang, C., & Wan, D. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c10656 · Cited by 46
The common fragile site FRA16D gene product WWOX: roles in tumor suppression and genomic stability
Aqeilan, R. I., Abu‐Remaileh, M., & Abu-Odeh, M. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-014-1724-y · Cited by 45
Zhang, P., Shao, Y., Fang, Q., Liu, L., & Yang, J. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119840 · Cited by 45
Hypoxic condition and prognosis in oral squamous cell carcinoma.
de Lima, P. O., Jorge, C. C., Oliveira, D. T., & Pereira, M. C. (2014) · PubMed · Cited by 56
Selvaraju, V., Parinandi, N. L., Adluri, R. S., Goldman, J. W., Hussain, N., Sanchez, J. A., & Maulik, N. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5186 · Cited by 45
Pernemalm, M., Petris, L. D., Branca, R. M., Forshed, J., Kanter, L., Soria, J., Girard, P., Validire, P., Yudi Pawitan, Y., van den Oord, J., et al. (2013) · Journal of Proteome Research · doi:10.1021/pr4002096 · Cited by 48
Totti, S., Allenby, M. C., Santos, S. B. D., Mantalaris, A., & Velliou, E. G. (2018) · RSC Advances · doi:10.1039/c8ra02633e · Cited by 46
Monteleone, F., Taverna, S., Alessandro, R., & Fontana, S. (2018) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-018-0843-y · Cited by 47
Choschzick, M., Lassen, P., Lebeau, A., Marx, A. H., Terracciano, L., Heilenkötter, U., Jaenicke, F., Bokemeyer, C., Izbicki, J. R., Sauter, G., et al. (2010) · Modern Pathology · doi:10.1038/modpathol.2010.5 · Cited by 44
Guimarães, T. A., Farias, L. C., Fraga, C. A. D. C., Feltenberger, J. D., Melo, G. A., Coletta, R. D., Santos, S. H. S., de Paula, A. M. B., & Guimarães, A. L. S. (2016) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000342 · Cited by 45
Lin, J., Li, D., Li, C., Zhuang, Z., Chu, C., Ostrikov, K., Thompson, E. W., Liu, G., & Wang, P. (2023) · Nanoscale · doi:10.1039/d3nr01735d · Cited by 46
Dai, C., Sun, F., Zhu, C., & Hu, X. (2013) · PLoS ONE · doi:10.1371/journal.pone.0063054 · Cited by 45
Koizume, S., Ito, S., Miyagi, E., Hirahara, F., Nakamura, Y., Sakuma, Y., Osaka, H., Takano, Y., Ruf, W., & Miyagi, Y. (2012) · Nucleic Acids Research · doi:10.1093/nar/gks201 · Cited by 47
Gomez-Roman, N., Sahasrabudhe, N. M., McGregor, F., Chalmers, A. J., Cassidy, J., & Plumb, J. A. (2016) · Oncotarget · doi:10.18632/oncotarget.7998 · Cited by 45
FAT1 is a novel upstream regulator of HIF1α and invasion of high grade glioma
Madan, E., Dikshit, B., Gowda, S. H., Srivastava, C., Sarkar, C., Chattopadhyay, P., Sinha, S., & Chosdol, K. (2016) · International Journal of Cancer · doi:10.1002/ijc.30386 · Cited by 46
Patra, M., Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Angewandte Chemie · doi:10.1002/ange.201510551 · Cited by 43
Yoo, S.-M., Lee, C., An, H., Lee, J. Y., Lee, H. S., Kang, H. C., Cho, S.-J., Kim, S. M., Park, J., Kim, D. J., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081994 · Cited by 43
Zhang, B., Huang, X., Wang, H., & Gou, S. (2019) · Journal of Materials Chemistry B · doi:10.1039/c9tb00541b · Cited by 43
Lee, Y., Nam, H.-S., Cho, M. K., & Lee, S.-H. (2020) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-020-03699-6 · Cited by 44
USP29 coordinates MYC and HIF1α stabilization to promote tumor metabolism and progression
Tu, R., Kang, W., Yang, M., Wang, L., Bao, Q., Chen, Z., Dong, Y., Wang, J., Jiang, J., Liu, H., et al. (2021) · Oncogene · doi:10.1038/s41388-021-02031-w · Cited by 44
Zhao, K., Wang, X., Zhao, D. H., Lin, Q., Zhang, Y., & Hu, Y. (2022) · Research · doi:10.34133/2022/9854904 · Cited by 48
Reactive Oxygen Species Responsive Nanoprodrug to Treat Intracranial Glioblastoma
Lee, B., Amano, T., Wang, H., Pantoja, J. L., Yoon, C. W., Hanson, C. J., Amatya, R., Yen, A., Black, K. L., & Yu, J. S. (2013) · ACS Nano · doi:10.1021/nn400347j · Cited by 43
Metadata
- Authors
- Denko, N. C.
- Affiliations
- Stanford Medicine (US)
- Corresponding author
- Denko, Nicholas C.
- ORCID
- Denko, Nicholas C.
- Venue
- Nature Reviews Cancer
- Published
- 2008-08-14
- Volume
- 8
- Issue
- 9
- Pages
- 705-713
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W2066379425
- Cited by
- 1,707
- References
- 126
- Citations by year
- 2026: 48 · 2025: 60 · 2024: 93 · 2023: 113 · 2022: 141 · 2021: 149 · 2020: 115 · 2019: 120 · 2018: 126 · 2017: 94 · 2016: 115 · 2015: 78 · 2014: 95 · 2013: 79 · 2012: 77
- FWCI
- 4.79
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Cancer Institute (P01CA067166)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Lipids, and Metabolism
- Keywords
- hypoxia, HIF-1, glucose metabolism, solid tumors, aerobic glycolysis, Warburg effect, cancer metabolism, mitochondrial activity, tumor growth
- MeSH terms
- Cell Division, Glucose, Glycolysis, Humans, Mitochondria, Models, Biological, Neoplasms, Cell Hypoxia, Gene Expression Regulation, Neoplastic, Reactive Oxygen Species, Hypoxia-Inducible Factor 1, Hypoxia-Inducible Factor 1, alpha Subunit
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.